Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.5 USD | +7.34% |
|
-2.86% | -44.28% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.52B 120B |
---|---|---|---|---|---|
Net income 2024 * | -237M -18.74B | Net income 2025 * | -271M -21.43B | EV / Sales 2024 * | - |
Net cash position 2024 * | 478M 37.79B | Net cash position 2025 * | 693M 54.81B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.41
x | P/E ratio 2025 * |
-6.06
x | Employees | 120 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.86% |
Latest transcript on Neumora Therapeutics, Inc.
1 day | +7.34% | ||
1 week | -2.86% | ||
Current month | -4.04% | ||
1 month | -1.55% | ||
3 months | -28.08% | ||
6 months | -45.71% | ||
Current year | -44.28% |
![Extreme 8.67](/images/extremecours_fleche.png)
![Extreme 8.67](/images/extremecours_fleche.png)
![Extreme 8.67](/images/extremecours_fleche.png)
![Extreme 8.67](/images/extremecours_fleche.png)
![Extreme 8.67](/images/extremecours_fleche.png)
![Extreme 8.67](/images/extremecours_fleche.png)
![Extreme 8.67](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Carol Suh
FOU | Founder | 33 | 31/10/19 |
Henry Gosebruch
CEO | Chief Executive Officer | 51 | 17/07/23 |
Paul Berns
FOU | Founder | 57 | 31/10/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Berns
FOU | Founder | 57 | 31/10/19 |
May Kin Ho
BRD | Director/Board Member | 71 | 31/03/21 |
Kristina Burow
BRD | Director/Board Member | 50 | 31/12/19 |
Date | Price | Change | Volume |
---|---|---|---|
21/06/24 | 9.5 | +7.34% | 1,264,445 |
20/06/24 | 8.85 | -3.28% | 951,158 |
18/06/24 | 9.15 | -2.45% | 836,697 |
17/06/24 | 9.38 | -4.09% | 403,297 |
14/06/24 | 9.78 | -1.71% | 376,381 |
Delayed Quote Nasdaq, June 21, 2024 at 09:00 pm
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.28% | 1.52B | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- NMRA Stock